Literature DB >> 17198836

Surgical damage of the saphenous vein and graft patency.

Michael R Dashwood, Andrzej Loesch.   

Abstract

Mesh：

Year:  2007        PMID： 17198836     DOI： 10.1016/j.jtcvs.2006.09.029

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  4 in total

Review 1.  Gene therapy for the prevention of vein graft disease.

Authors:  Kevin W Southerland; Sarah B Frazier; Dawn E Bowles; Carmelo A Milano; Christopher D Kontos
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

2.  Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo.

Authors:  Akihito Muto; Alyssa Panitch; Namho Kim; Kinam Park; Padmini Komalavilas; Colleen M Brophy; Alan Dardik
Journal:  Vascul Pharmacol       Date:  2011-10-17       Impact factor: 5.773

3.  Perivascular Adipose Tissue Is a Major Source of Nitric Oxide in Saphenous Vein Grafts Harvested via the No-Touch Technique.

Authors:  Toshiro Saito; Hiroshi Kurazumi; Ryo Suzuki; Kazumasa Matsunaga; Sarii Tsubone; Bochao Lv; Sei Kobayashi; Takashi Nagase; Takahiro Mizoguchi; Makoto Samura; Kotaro Suehiro; Takasuke Harada; Noriyasu Morikage; Akihito Mikamo; Kimikazu Hamano
Journal:  J Am Heart Assoc       Date:  2022-01-19       Impact factor: 6.106

4.  Preserving the endothelium in saphenous vein graft with both conventional and no-touch preparation.

Authors:  Toshiro Saito; Hiroshi Kurazumi; Ryo Suzuki; Yutaro Matsuno; Akihito Mikamo; Kimikazu Hamano
Journal:  J Cardiothorac Surg       Date:  2020-10-15       Impact factor: 1.637
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.